Farther Finance Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
CAM
IA
SOADOR
LSERS
PFSRSONJ
YCM
TAM
Farther Finance Advisors's TGTX Position: Q2 2026 in Review
Farther Finance Advisors increased its TG Therapeutics (TGTX) stake by 30% in Q2 2026, buying an estimated $6.38K and bringing the position to 681 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3484.
Farther Finance Advisors first reported a position in TGTX in Q4 2022 and has held it in 13 quarters since. 78 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Farther Finance Advisors held 681 shares of TG Therapeutics worth $37.5K as of Q2 2026.
- Farther Finance Advisors bought 156 TG Therapeutics shares in Q2 2026, an estimated $6.38K.
- TG Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3484 holding.
- Farther Finance Advisors first reported a position in TG Therapeutics in Q4 2022 and has held it in 13 quarters since.
- 78 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.